{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:46:25Z","timestamp":1791413185747,"version":"4.3.3"},"reference-count":32,"publisher":"American Society for Clinical Investigation","issue":"16","license":[{"start":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T00:00:00Z","timestamp":1692057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"crossref","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,15]]},"DOI":"10.1172\/jci167818","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T12:01:24Z","timestamp":1688040084000},"source":"Crossref","is-referenced-by-count":19,"title":["Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model"],"prefix":"10.1172","volume":"133","author":[{"given":"Elena","family":"Bekerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Yant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"VanderVeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Callebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2023,8,15]]},"reference":[{"key":"B1","unstructured":"CDC. Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through June 2021; and Preexposure Prophylaxis (PrEP) Data Reported through March 2021. https:\/\/www.cdc.gov\/hiv\/library\/reports\/surveillance-data-tables\/ Updated October, 2021 Accessed Dec 12, 2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22692"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000472"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115542"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa476"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e328358e484"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050028"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1338"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000738"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04279-4"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2443-1"},{"key":"B12","unstructured":"Yant SR, et al. GS-6207, A potent and selective first-in-class long-acting HIV-1 capsid inhibitor. Conference on Retroviruses and Opportunistic Infections. https:\/\/www.croiconference.org\/abstract\/gs-6207-potent-and-selective-first-class-long-acting-hiv-1-capsid-inhibitor\/ Accessed July 21, 2023"},{"key":"B13","unstructured":"Jogiraju V, et al. Pharmacokinetics of a simplified subcutaneous lenacapavir regimen versus Phase 2\/3 regimen. 24th International AIDS Conference. https:\/\/programme.aids2022.org\/Abstract\/Abstract\/?abstractid=5490 Accessed July 21, 2023"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.10.5074-5077.2006"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001896"},{"key":"B16","unstructured":"Smith RA, et al. Antiviral activity of lenacapavir against HIV-2 isolates. Conference on retroviruses and opportunistic infections. https:\/\/www.croiconference.org\/abstract\/antiviral-activity-of-lenacapavir-against-hiv-2-isolates\/ Accessed July 21, 2023"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb4808"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000735"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031738"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz271"},{"issue":"5","key":"B22","article-title":"Carbon Tetrachloride, Merck","volume":"65","author":"Merck","year":"1930","journal-title":"Ind Med Gaz"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000746"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003322"},{"key":"B25","unstructured":"Landovitz RJ, et al. Updated efficacy, safety, and case studies in HPTN 083: CAB-LA vs TDF\/FTC for PrEP. Conference on retroviruses and opportunistic infections. https:\/\/www.croiconference.org\/abstract\/updated-efficacy-safety-and-case-studies-in-hptn-083-cab-la-vs-tdf-ftc-for-prep\/ Accessed July 21, 2023"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab152"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac415"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02057-20"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab503"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac364"},{"key":"B31","unstructured":"Begley R, et al. GS-6207 sustained delivery formulation supports 6-month dosing interval. 23rd International AIDS Conference. https:\/\/programme.aids2020.org\/Abstract\/Abstract\/8533 Accessed July 21, 2023"},{"key":"B32","unstructured":"GileadSciences. Purpose studies. https:\/\/www.purposestudies.com\/ Updated October 5, 2022 Accessed March 23, 2022. Accessed March 23, 2022"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/167818\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T14:01:09Z","timestamp":1692021669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/167818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":32,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2023,8,15]]},"published-print":{"date-parts":[[2023,8,15]]}},"alternative-id":["10.1172\/JCI167818"],"URL":"https:\/\/doi.org\/10.1172\/jci167818","relation":{},"ISSN":["1558-8238"],"issn-type":[{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,15]]},"article-number":"e167818"}}